Our business

Delivering a smoke-free future

Our current product portfolio primarily consists of cigarettes and smoke-free products, including heated tobacco, e-vapor, and oral smokeless products.

As of June 30, 2024, 38 percent of our total net revenues came from our smoke-free products.

By 2030, our ambition is to increase that figure to over two-thirds, with the ultimate goal of phasing out cigarettes completely. Leveraging our scientific expertise and technological capabilities, we are also committed to developing new products in the wellness and healthcare space.

Our progress toward a smoke-free future as of Q2 2024

38 percent

of PMI’s total net revenues came from our smoke-free business.
36.5 million

estimated total adult users of PMI’s smoke-free products. ¹
90 markets

where our smoke-free products are available. ¹
USD >12.5 billion

invested to develop, scientifically substantiate, and commercialize smoke-free products since 2008. ²

¹ As of June 30, 2024. ² As of December 31, 2023. Important Note: This information should be read in conjunction with the Philip Morris International Inc. earnings release dated July 23, 2024, as well as the accompanying glossary of key terms, definitions, explanatory notes, select financial information and reconciliations of non-GAAP financial measures, both of which are available on our Investor Relations pages. “PMI” refers to Philip Morris International Inc. and its subsidiaries.